Trial reportObesity (Silver Spring, Md.)2026
The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER-Remote Trial.
Trial report in Obesity (Silver Spring, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01871116 (A Randomized Study Evaluating the Effect of a Remote-Based Weight Loss Program), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Study Evaluating the Effect of a Remote-Based Weight Loss Program (POWER-remote) on Biomarkers in Women With Early Stage Breast Cancer
Who cites it
1 citing paper in PubMed.
- The Impact of Baseline Sleep as a Potential Moderator of Weight Loss Intervention in Breast Cancer Survivors: Results From the POWER-Remote Trial.Obesity (Silver Spring, Md.) · 2026Trial
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
objectiveWe evaluated whether sleep disturbance moderates weight loss in breast cancer survivors. We hypothesized that poor sleep prior to behavioral weight loss (BWL) would be associated with less weight reduction than better sleep.
methodsWomen with prior stage 0-III breast cancer with BMI ≥ 25 kg/m
resultsThere was significant interaction between baseline sleep and treatment (BWL vs. self-directed) for weight loss at 6 (p = 0.024) and 12 months (p = 0.019). Weight loss among better sleepers was -6.16% (SE 1.42%) in BWL versus self-directed arms and -7.53% (SE 2.02%) at 6 (p < 0.001) and 12 months (p = 0.001), respectively. Among poor sleepers, weight loss was -3.15% (SE: 1.58%) and -2.44% (SE: 2.40%) at 6 (p = 0.056) and 12 months (p = 0.321), respectively. BWL had a greater effect among better sleepers but minimal effect among poor sleepers.
conclusionsBWL has greater effects in breast cancer survivors with better versus worse sleep. Studies should evaluate whether sleep disturbance treatment augments weight loss.
trial registrationClinicalTrials.gov identifier NCT01871116.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.